Clinical-stage biopharmaceutical company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Alumis Inc. in the last 30 days yet.
The 1 sources with the most insights about Alumis Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Mentioned as a relevant company in the specialized biotech and rare disease space.
Mentioned as a relevant company in the specialized biotech and rare disease space.
Other assets that creators frequently mention in the same content as Alumis Inc..
The most active sources covering Alumis Inc. (ALMS) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Alumis Inc. (ALMS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Alumis Inc. (ALMS) most frequently also discuss SPRB, BHVN, RGTI, COHR, BMY. See the "Discussed alongside" section above for full asset pages.